Reported Jul 28, 2021 · Terminated

Erythromycin Topical Gel, 2%, Net Wt. (a) 30 g,(NDC 52565-033-30) (b) 60 g,(NDC 52565-033-60) Rx Only, Manufactured by:…

Teligent Pharma, Inc.

Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: Teligent Pharma, Inc. · 105 Lincoln Avenue · Buena, NJ · 08310

Is this the product you have?

    • Erythromycin Topical Gel
    • 2%
    • Net Wt. (a) 30 g
    • (NDC 52565-033-30) (b) 60 g
    • (NDC 52565-033-60) Rx Only
  • Manufactured byTeligent Pharma, Inc. , Buena, NJ 08310
Lot codes and dates
    • 1) NDC 52565-033-30 Lot 14010
    • Exp July 2021
    • 2) NDC 52565-033-60 Lot 13865
    • Exp June 2021
    • Lot 14011
    • Exp July 2021
Amount recalled
22,824 tubes

This recall covers 2 products

The agency filed one notice per product. You are reading one of them; the other one is below.

Where it was sold

  • Nationwide

Why it was recalled

Failed Impurities/Degradation Specifications

This product is unlikely to cause harm, but it breaks a safety or labelling rule.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new Teligent Pharma, Inc. recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration (openFDA)

Read the FDA (openFDA drug enforcement) notice

Notice updated Jul 3, 2024 · Data as of Sep 19, 8:07 PM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.